Took all the data from the two new slides and tabulated it, some may find it helpful. Days on study and tumour size are eye-balled and subjective.
Then overlaid the new data onto the slide I'm most familiar with of the MAST trial mono vs. combo dose escalation and it came out looking like the following:
The cohorts crossed out mean all patients in those cohorts are now off the study, N/A means no treatment result at this time. N is the number of patients in the cohort. Best wishes to those patients in the Mono cohort 3, looks like this is the set to watch for the next lot of results.
Took all the data from the two new slides and tabulated it, some...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.0¢ |
Change
-0.004(6.25%) |
Mkt cap ! $439.1M | |||
| Open | High | Low | Value | Volume |
| 6.4¢ | 6.5¢ | 5.9¢ | $2.751M | 44.93M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 1171830 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 1188733 | 16 |
View Market Depth
| Last trade - 16.10pm 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
6.0¢ |
Change
-0.004 ( 6.25 %) |
||||
| Open | High | Low | Volume | ||
| 6.4¢ | 6.5¢ | 5.9¢ | 22305109 | ||
| Last updated 15.59pm 04/06/2024 ? | |||||
| IMU (ASX) Chart |